Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Early diagnosis needed for young adults with lung cancer
Alexandra Potter - Massachusetts General Hospital, Boston, USA
Early diagnosis needed for young adults with lung cancer ( Alexandra Potter - Massachusetts General Hospital, Boston, USA )
11 Aug 2022
Topics under discussion at the WCLC 2022 presidential symposium
Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Topics under discussion at the WCLC 2022 presidential symposium ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
9 Aug 2022
Atezolizumab vs best supportive care in resected NSCLC
Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Atezolizumab vs best supportive care in resected NSCLC ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
9 Aug 2022
MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC
Dr Jonathan Strickler - Duke Cancer Institute, Durham, USA
MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC ( Dr Jonathan Strickler - Duke Cancer Institute, Durham, USA )
8 Aug 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022
Impact of BRAF-V600E mutation on the tumour microenvironment and associated geno...
Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer ( Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA )
20 Jul 2022
Low-dose nivolumab leads to improved overall survival for head and neck cancer p...
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Low-dose nivolumab leads to improved overall survival for head and neck cancer patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022
Updates from the PROpel and MAGNITUDE studies
Prof Phil Cornford and Dr Elena Castro
Updates from the PROpel and MAGNITUDE studies ( Prof Phil Cornford and Dr Elena Castro )
11 Jul 2022
Update on the latest in PARP inhibitors for prostate cancer
Prof Axel Merseburger and Prof Bertrand Tombal
Update on the latest in PARP inhibitors for prostate cancer ( Prof Axel Merseburger and Prof Bertrand Tombal )
11 Jul 2022
Prostate roundup what have we learned from EAU and ASCO 2022?
Prof Eleni Efstathiou and Prof Nicolas Mottet
Prostate roundup what have we learned from EAU and ASCO 2022? ( Prof Eleni Efstathiou and Prof Nicolas Mottet )
11 Jul 2022
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM
Dr Maximilian Merz - Leipzig University, Leipzig, Germany
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM ( Dr Maximilian Merz - Leipzig University, Leipzig, Germany )
11 Jul 2022